165 related articles for article (PubMed ID: 31035404)
1. Design, Synthesis, and Mechanism of Dihydroartemisinin⁻Coumarin Hybrids as Potential Anti-Neuroinflammatory Agents.
Yu H; Hou Z; Yang X; Mou Y; Guo C
Molecules; 2019 Apr; 24(9):. PubMed ID: 31035404
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents.
Yu H; Hou Z; Tian Y; Mou Y; Guo C
Eur J Med Chem; 2018 May; 151():434-449. PubMed ID: 29649740
[TBL] [Abstract][Full Text] [Related]
3. Molecular Docking, Synthesis, and Characterization of Furanyl-Pyrazolyl Acetamide and 2,4-Thiazolidinyl-Furan-3-Carboxamide Derivatives as Neuroinflammatory Protective Agents.
Mudimela S; Giridharan VV; Janardhan S
Chem Biodivers; 2024 May; 21(5):e202301260. PubMed ID: 38513005
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis and Cytotoxicity of Novel Dihydroartemisinin-Coumarin Hybrids via Click Chemistry.
Tian Y; Liang Z; Xu H; Mou Y; Guo C
Molecules; 2016 Jun; 21(6):. PubMed ID: 27294901
[TBL] [Abstract][Full Text] [Related]
5. Bioactive sesquiterpene coumarins from the resin of Ferula sinkiangensis targeted on over-activation of microglia.
Guo T; Zhou D; Yang Y; Zhang X; Chen G; Lin B; Sun Y; Ni H; Liu J; Hou Y; Li N
Bioorg Chem; 2020 Nov; 104():104338. PubMed ID: 33142410
[TBL] [Abstract][Full Text] [Related]
6. Functional Selectivity of Coumarin Derivates Acting via GPR55 in Neuroinflammation.
Apweiler M; Streyczek J; Saliba SW; Collado JA; Hurrle T; Gräßle S; Muñoz E; Normann C; Hellwig S; Bräse S; Fiebich BL
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055142
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel S-linked dihydroartemisinin derivatives and evaluation of their anticancer activity.
Gour R; Ahmad F; Prajapati SK; Giri SK; Lal Karna SK; Kartha KPR; Pokharel YR
Eur J Med Chem; 2019 Sep; 178():552-570. PubMed ID: 31216504
[TBL] [Abstract][Full Text] [Related]
8. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
9. Triazole tethered C5-curcuminoid-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Kumar M; Nepali K; Gupta MK; Saxena AK; Sharma S; Bedi PMS
Eur J Med Chem; 2016 Jun; 116():102-115. PubMed ID: 27060762
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vivo analgesic and anti-inflammatory activity of some bi heterocyclic coumarin derivatives.
Ghate M; Kusanur RA; Kulkarni MV
Eur J Med Chem; 2005 Sep; 40(9):882-7. PubMed ID: 16140424
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and antitumor activity of novel artemisinin derivatives using hybrid approach.
Xie L; Zhai X; Ren L; Meng H; Liu C; Zhu W; Zhao Y
Chem Pharm Bull (Tokyo); 2011; 59(8):984-90. PubMed ID: 21804243
[TBL] [Abstract][Full Text] [Related]
12. Molecular Basis of Artemisinin Derivatives Inhibition of Myeloid Differentiation Protein 2 by Combined in Silico and Experimental Study.
Qiao S; Zhang H; Sun F; Jiang Z
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577169
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
An R; Hou Z; Li JT; Yu HN; Mou YH; Guo C
Molecules; 2018 Sep; 23(9):. PubMed ID: 30200625
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents.
Abdizadeh T; Kalani MR; Abnous K; Tayarani-Najaran Z; Khashyarmanesh BZ; Abdizadeh R; Ghodsi R; Hadizadeh F
Eur J Med Chem; 2017 May; 132():42-62. PubMed ID: 28340413
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological evaluation of 9,10-dihydrochromeno[8,7-e][1,3]oxazin-2(8H)-one derivatives as potent anti-inflammatory agent.
Zhang HJ; Li YF; Cao Q; Tian YS; Quan ZS
Pharmacol Rep; 2017 Jun; 69(3):419-425. PubMed ID: 28273501
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
Paul K; Bindal S; Luxami V
Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
[TBL] [Abstract][Full Text] [Related]
17. Piperazine and piperidine-substituted 7-hydroxy coumarins for the development of anti-inflammatory agents.
Buran K; Reis R; Sipahi H; Önen Bayram FE
Arch Pharm (Weinheim); 2021 Jul; 354(7):e2000354. PubMed ID: 33749005
[TBL] [Abstract][Full Text] [Related]
18. Coumarin hybrids as novel therapeutic agents.
Sandhu S; Bansal Y; Silakari O; Bansal G
Bioorg Med Chem; 2014 Aug; 22(15):3806-14. PubMed ID: 24934993
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells.
Dhawan S; Kerru N; Awolade P; Singh-Pillay A; Saha ST; Kaur M; Jonnalagadda SB; Singh P
Bioorg Med Chem; 2018 Nov; 26(21):5612-5623. PubMed ID: 30360952
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory screening and molecular modeling of some novel coumarin derivatives.
El-Haggar R; Al-Wabli RI
Molecules; 2015 Mar; 20(4):5374-91. PubMed ID: 25822078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
